D. Vasile

713 total citations · 1 hit paper
27 papers, 501 citations indexed

About

D. Vasile is a scholar working on Psychiatry and Mental health, Pharmacology and Clinical Psychology. According to data from OpenAlex, D. Vasile has authored 27 papers receiving a total of 501 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Psychiatry and Mental health, 9 papers in Pharmacology and 8 papers in Clinical Psychology. Recurrent topics in D. Vasile's work include Treatment of Major Depression (6 papers), Schizophrenia research and treatment (5 papers) and Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes (4 papers). D. Vasile is often cited by papers focused on Treatment of Major Depression (6 papers), Schizophrenia research and treatment (5 papers) and Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes (4 papers). D. Vasile collaborates with scholars based in United Kingdom, Netherlands and United States. D. Vasile's co-authors include Wiesław Jerzy Cubała, Paul D. Morrison, Adam Taylor, Philip McGuire, Stephen Wright, Philip Robson, Rachel Barron, Octavian Vasiliu, Shazia Anwer Bukhari and Lorena Dima and has published in prestigious journals such as SHILAP Revista de lepidopterología, American Journal of Psychiatry and Schizophrenia Bulletin.

In The Last Decade

D. Vasile

20 papers receiving 460 citations

Hit Papers

Cannabidiol (CBD) as an Adjunctive Therapy in Schizophren... 2017 2026 2020 2023 2017 100 200 300 400

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
D. Vasile United Kingdom 6 395 150 123 74 65 27 501
Rachel Barron United Kingdom 4 463 1.2× 138 0.9× 122 1.0× 73 1.0× 49 0.8× 6 554
Halle Thurnauer United States 5 443 1.1× 98 0.7× 229 1.9× 111 1.5× 38 0.6× 5 533
Amaya Austrich-Olivares Spain 8 340 0.9× 73 0.5× 152 1.2× 80 1.1× 62 1.0× 10 601
Lucy Walker United Kingdom 7 375 0.9× 104 0.7× 161 1.3× 97 1.3× 140 2.2× 7 566
Aarti Gupta United States 7 270 0.7× 94 0.6× 103 0.8× 56 0.8× 32 0.5× 17 396
Robin Wilson United Kingdom 13 370 0.9× 222 1.5× 177 1.4× 194 2.6× 81 1.2× 23 691
Rachel Lees United Kingdom 11 541 1.4× 130 0.9× 190 1.5× 122 1.6× 102 1.6× 27 670
Lisa‐Marie Greenwood Australia 13 306 0.8× 72 0.5× 140 1.1× 162 2.2× 130 2.0× 37 558
Ashley M. Schnakenberg Martin United States 14 401 1.0× 196 1.3× 273 2.2× 189 2.6× 126 1.9× 35 746
Richard Whale United Kingdom 12 130 0.3× 147 1.0× 158 1.3× 66 0.9× 52 0.8× 32 554

Countries citing papers authored by D. Vasile

Since Specialization
Citations

This map shows the geographic impact of D. Vasile's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D. Vasile with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D. Vasile more than expected).

Fields of papers citing papers by D. Vasile

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D. Vasile. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D. Vasile. The network helps show where D. Vasile may publish in the future.

Co-authorship network of co-authors of D. Vasile

This figure shows the co-authorship network connecting the top 25 collaborators of D. Vasile. A scholar is included among the top collaborators of D. Vasile based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D. Vasile. D. Vasile is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Vasiliu, Octavian, et al.. (2022). Analysis of COVID-19-related psychiatric disorders: clinical manifestations and therapeutic considerations. Romanian Journal of Military Medicine. 125(3). 382–390. 3 indexed citations
2.
Vasiliu, Octavian, et al.. (2021). Diagnostic and treatment features of work stress-related disorders in healthcare professionals in the context of COVID-19 pandemic. SHILAP Revista de lepidopterología. 3(66). 22–22. 1 indexed citations
3.
Vasile, D., et al.. (2021). Third generation cognitive-behavioral therapies for major depressive disorder- a literature review. European Psychiatry. 64(S1). S325–S325.
5.
Vasiliu, Octavian, et al.. (2020). Current treatment of posttraumatic stress disorder – A review of therapeutic guidelines and good practice recommendations. Romanian Journal of Military Medicine. 123(4). 241–248. 4 indexed citations
6.
Vasiliu, Octavian, et al.. (2018). Analysis of risk factors for antipsychotic-resistant schizophrenia in young patients – A retrospective analysis. Romanian Journal of Military Medicine. 121(1). 25–29. 5 indexed citations
7.
Vasiliu, Octavian, et al.. (2018). Translational approaches in treatment-resistant depression based on animal model.. PubMed. 59(3). 955–964. 5 indexed citations
8.
Vasiliu, Octavian & D. Vasile. (2017). Analysis of Comorbidities in A Group of Young Patients Diagnosed with Internet Addiction. The Internet of Things. 2. 1 indexed citations
9.
Vasiliu, Octavian, et al.. (2017). Cell Phone Addiction: A Review of the Available Data. International journal of communication. 2. 1 indexed citations
10.
McGuire, Philip, Philip Robson, Wiesław Jerzy Cubała, et al.. (2017). Cannabidiol (CBD) as an Adjunctive Therapy in Schizophrenia: A Multicenter Randomized Controlled Trial. American Journal of Psychiatry. 175(3). 225–231. 428 indexed citations breakdown →
11.
Vasiliu, Octavian & D. Vasile. (2016). Risk factors and quality of life in late-life depressive disorders. SHILAP Revista de lepidopterología. 119(3). 24–28. 7 indexed citations
12.
Dima, Lorena, D. Vasile, Liliana Rogozea, et al.. (2015). Self-perception of quality of life in patients treated with antipsychotics. TURKISH JOURNAL OF MEDICAL SCIENCES. 45(4). 782–788. 4 indexed citations
13.
Vasile, D., et al.. (2014). P.2.f.008 SSRI dose escalation versus duloxetine in treatment of major depressive disorder not responding to initial SSRI. European Neuropsychopharmacology. 24. S455–S456. 5 indexed citations
14.
Vasile, D., Radu Alexandru Macovei, & Octavian Vasiliu. (2013). P.2.b.007 Efficacy and tolerability of bupropion in major depressive disorder associated with Parkinson's disease. European Neuropsychopharmacology. 23. S322–S323. 2 indexed citations
15.
Vasile, D., et al.. (2011). P.2.c.002 Agomelatine versus selective serotoninergic reuptake inhibitors in major depressive disorder and comorbid diabetes mellitus. European Neuropsychopharmacology. 21. S383–S384. 6 indexed citations
16.
Anand, Ravi, et al.. (2010). An Open-Label Tolerability Study of BL-1020 Antipsychotic. Clinical Neuropharmacology. 33(6). 297–302. 5 indexed citations
17.
Vasile, D., et al.. (2010). P.2.g.008 Efficacy of milnacipran in patients with interferon-a2 induced depression. European Neuropsychopharmacology. 20. S425–S425. 1 indexed citations
18.
Vasile, D., et al.. (2010). P.5.a.007 Comparative efficacy of cholinesterase inhibitors in dementia associated with Parkinson's disease. European Neuropsychopharmacology. 20. S553–S554. 1 indexed citations
19.
20.
Vasile, D., et al.. (2006). P.3.c.014 Side effects of atypical antipsychotics - prediction factor for compliance. European Neuropsychopharmacology. 16. S404–S404. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026